Entity

Time filter

Source Type

Louisville, KY, United States

Methods and compositions relate to genetic markers of psychotic disorders, e.g., schizophrenia (SZ), are provided. For example, in certain aspects methods for determinations of a OPRP genetic signature are described. Furthermore, the invention provides methods and compositions involving treatment of psychotic disorders using the genetic signature.


Patent
SureGene | Date: 2013-10-29

This invention relates to genetic markers of mental illness, e.g., schizophrenia (SZ), and methods of use thereof.


Patent
SureGene | Date: 2014-10-17

This invention relates to genetic markers of mental illness, e.g., schizophrenia (SZ) and methods of use thereof.


Patent
SureGene | Date: 2014-06-10

Provided herein are genetic markers for predicting response to antipsychotic treatment. Identification of the disclosed SNPs can be used to predict response to antipsychotic drugs in patients suffering from schizophrenia.


This document provides methods and materials related to genetic markers for predicting response to a treatment for schizophrenia (SZ). For example, methods for using such genetic markers to select optimal treatments are provided.

Discover hidden collaborations